OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for t...
— ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform of CD24 (neoCD24) ...
— ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform of CD24 (neoCD24) ...
Empowering Creative Play for The Next Generation TORONTO, Aug. 17, 2026 /PRNewswire/ — Spin Master, a leading global c...
Hyderabad: The Akhil Bharatiya Vidyarthi Parishad (ABVP) EFLU Unit has alleged that its karyakartas and students were su...
PM Modi | Independence Day | "மாற்றத்துக்கான பாதையை Gen Z தலைமுறை ...
One of the greatest regrets of the Kamala Harris campaign after she lost was that she didn’t appear on Joe Rogan’s ...
Discover seven essential books on India's pre-1947 business pioneers whose vision, enterprise, and leadership helped sha...
HONG KONG, Aug. 15, 2026 /PRNewswire/ -- The exceptional research strengths of City University of Hong Kong (CityUHK) ha...
The Seattle Seahawks inked three-time Pro Bowler Devon Witherspoon to a four-year, $132 million extension on Saturday th...